fbpx

ADVERTISEMENT

ADVERTISEMENT

Sickle Cell Anemia

Updated : April 19, 2023





Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

 

voxelotor 

Administer 1500mg orally every day
Hydroxyurea can be used along if needed



Dose Adjustments

Renal impairment: No dosage adjustment is necessary
Hepatic impairment:
Mild to moderate: No dosage adjustment necessary (Child A pugh or B)
Severe: Reduce to 1000 mg every day or 900 mg oral suspension orally every day (Child-Pugh C)

CYP3A4 inducers
Avoid administering CYP3A4 inducers in combination, whether they are strong or mild.
Increase dosage to 2500 mg orally once a day for strong CYP3A4 inducers.
Increase to 2,000 mg orally every day for moderate CYP3A4 inducers.

lovotibeglogene autotemcel (FDA Approval Pending) 

FDA Approval Pending as one-time gene therapy for sickle cell disease in patients aged ≥12 years



hydroxycarbamide 

According to response and blood count, the Initial dose of 15 mg/kg orally daily by 2.5 to 5 mg/kg every 12 weeks. Usual dosage: 15 to 30 mg/kg every day. Maximum dose: 35 mg/kg daily



Dose Adjustments

Dosing modifications
Renal impairment: CrCl less than 60 ml/min: 7.5 mg/kg daily, titrate based on the response
Hepatic impairment: Severe (Child-Pugh score C): Contraindicated

 

hydroxyurea

initial dose :

20

mg/kg

Orally

once a day

Increase 5 mg per kg per day every eight weeks depending on the severity <>br maximum dose: 35 mg/kg per day
The blood counts need to be monitored



voxelotor 


<4 years: Safety and efficacy not established
>12 years: Administer 1500mg orally every day
4 to 11 years:
10 to <20 kg: 600mg orally every day
20 to <40kg: 900mg orally every day
≥40kg: 1500mg orally every day



Dose Adjustments


Renal impairment: No dosage adjustment is necessary
Hepatic impairment:
Mild to moderate: No dosage adjustment necessary (Child A pugh or B)
Severe: Reduce to 1000 mg orally every day or 900 mg oral suspension orally every day (Child-Pugh C)
20 kg to <40kg: Reduce the dose to 600mg orally every day
10 kg to <20kg: Reduce the dosage to 300mg orally every day

lovotibeglogene autotemcel (FDA Approval Pending) 

FDA Approval Pending as one-time gene therapy for sickle cell disease in patients aged ≥12 years



 

Media Gallary

References

ADVERTISEMENT 

Sickle Cell Anemia

Updated : April 19, 2023




voxelotor 

Administer 1500mg orally every day
Hydroxyurea can be used along if needed



Dose Adjustments

Renal impairment: No dosage adjustment is necessary
Hepatic impairment:
Mild to moderate: No dosage adjustment necessary (Child A pugh or B)
Severe: Reduce to 1000 mg every day or 900 mg oral suspension orally every day (Child-Pugh C)

CYP3A4 inducers
Avoid administering CYP3A4 inducers in combination, whether they are strong or mild.
Increase dosage to 2500 mg orally once a day for strong CYP3A4 inducers.
Increase to 2,000 mg orally every day for moderate CYP3A4 inducers.

lovotibeglogene autotemcel (FDA Approval Pending) 

FDA Approval Pending as one-time gene therapy for sickle cell disease in patients aged ≥12 years



hydroxycarbamide 

According to response and blood count, the Initial dose of 15 mg/kg orally daily by 2.5 to 5 mg/kg every 12 weeks. Usual dosage: 15 to 30 mg/kg every day. Maximum dose: 35 mg/kg daily



Dose Adjustments

Dosing modifications
Renal impairment: CrCl less than 60 ml/min: 7.5 mg/kg daily, titrate based on the response
Hepatic impairment: Severe (Child-Pugh score C): Contraindicated

hydroxyurea

initial dose :

20

mg/kg

Orally

once a day

Increase 5 mg per kg per day every eight weeks depending on the severity <>br maximum dose: 35 mg/kg per day
The blood counts need to be monitored



voxelotor 


<4 years: Safety and efficacy not established
>12 years: Administer 1500mg orally every day
4 to 11 years:
10 to <20 kg: 600mg orally every day
20 to <40kg: 900mg orally every day
≥40kg: 1500mg orally every day



Dose Adjustments


Renal impairment: No dosage adjustment is necessary
Hepatic impairment:
Mild to moderate: No dosage adjustment necessary (Child A pugh or B)
Severe: Reduce to 1000 mg orally every day or 900 mg oral suspension orally every day (Child-Pugh C)
20 kg to <40kg: Reduce the dose to 600mg orally every day
10 kg to <20kg: Reduce the dosage to 300mg orally every day

lovotibeglogene autotemcel (FDA Approval Pending) 

FDA Approval Pending as one-time gene therapy for sickle cell disease in patients aged ≥12 years



Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses